[Fulminant autoimmune hemolytic anemia with multiple organ failure]. 1989

S Okada, and Y Miyoshi, and Y Takizawa, and S Hagiwara, and H Mori, and H Niikura, and H Terada, and H Watanabe, and T Mitsuya, and F Sagawa

We report a rare case of fulminant autoimmune hemolytic anemia (AIHA) with multiple organ failure (MOF). A 40-year-old man was emergently admitted to our hospital because of conscious disturbance and jaundice. The peripheral blood revealed RBC 68 x 10(4)/microliter, Hb 3.5 g/dl, Ht 8.9%, Ret 30% (20,400/microliter), WBC 20,300/microliter, Plts 16.9 x 10(4)/microliter, indirect bilirubin 9.4 mg/dl. Both direct and indirect Coombs test were positive and the IgG autoantibody was identified. Bone marrow aspiration revealed hypercellularity with increased megakaryocytes and erythroid hyperplasia. The patient was diagnosed as having idiopathic warm type of AIHA and the therapy was started with prednisolone 80 mg/day from the first day of admission but hemolysis with reticulocytopenia was so rapidly progressive that he was in acutely life-threatening state and MOF (acute renal failure, adult respiratory distress syndrome, congestive heart failure, liver dysfunction, rhabdomyolysis) appeared on the third hospital day. Plasma exchange therapy and hemodialysis were started and high dose methylprednisolone was given soon after rapid administration of sufficient blood transfusion. Dramatic improvement of hemolysis was noted and MOF was controlled after starting these therapies, but he died of exacerbation of MOF probably due to sepsis 40 days later.

UI MeSH Term Description Entries
D008297 Male Males
D009102 Multiple Organ Failure A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative. MODS,Multiple Organ Dysfunction Syndrome,Organ Dysfunction Syndrome, Multiple,Organ Failure, Multiple,Failure, Multiple Organ,Multiple Organ Failures
D010951 Plasma Exchange Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. Exchange, Plasma,Exchanges, Plasma,Plasma Exchanges
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000744 Anemia, Hemolytic, Autoimmune Acquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient's own RED BLOOD CELLS. Anemia, Hemolytic, Idiopathic Acquired,Autoimmune Haemolytic Anaemia,Autoimmune Hemolytic Anemia,Cold Agglutinin Disease,Hemolytic Anemia, Autoimmune,Acquired Autoimmune Hemolytic Anemia,Anemia, Hemolytic, Cold Antibody,Cold Antibody Disease,Cold Antibody Hemolytic Anemia,Idiopathic Autoimmune Hemolytic Anemia,Agglutinin Disease, Cold,Anaemia, Autoimmune Haemolytic,Anemia, Autoimmune Hemolytic,Autoimmune Haemolytic Anaemias,Autoimmune Hemolytic Anemias,Cold Agglutinin Diseases,Cold Antibody Diseases,Haemolytic Anaemia, Autoimmune

Related Publications

S Okada, and Y Miyoshi, and Y Takizawa, and S Hagiwara, and H Mori, and H Niikura, and H Terada, and H Watanabe, and T Mitsuya, and F Sagawa
January 1981, Pediatrie,
S Okada, and Y Miyoshi, and Y Takizawa, and S Hagiwara, and H Mori, and H Niikura, and H Terada, and H Watanabe, and T Mitsuya, and F Sagawa
August 2002, The Journal of infection,
S Okada, and Y Miyoshi, and Y Takizawa, and S Hagiwara, and H Mori, and H Niikura, and H Terada, and H Watanabe, and T Mitsuya, and F Sagawa
September 2014, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion,
S Okada, and Y Miyoshi, and Y Takizawa, and S Hagiwara, and H Mori, and H Niikura, and H Terada, and H Watanabe, and T Mitsuya, and F Sagawa
January 1994, Haematologica,
S Okada, and Y Miyoshi, and Y Takizawa, and S Hagiwara, and H Mori, and H Niikura, and H Terada, and H Watanabe, and T Mitsuya, and F Sagawa
June 2016, Pediatrics international : official journal of the Japan Pediatric Society,
S Okada, and Y Miyoshi, and Y Takizawa, and S Hagiwara, and H Mori, and H Niikura, and H Terada, and H Watanabe, and T Mitsuya, and F Sagawa
November 2013, Presse medicale (Paris, France : 1983),
S Okada, and Y Miyoshi, and Y Takizawa, and S Hagiwara, and H Mori, and H Niikura, and H Terada, and H Watanabe, and T Mitsuya, and F Sagawa
August 2006, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S Okada, and Y Miyoshi, and Y Takizawa, and S Hagiwara, and H Mori, and H Niikura, and H Terada, and H Watanabe, and T Mitsuya, and F Sagawa
March 2015, Chest,
S Okada, and Y Miyoshi, and Y Takizawa, and S Hagiwara, and H Mori, and H Niikura, and H Terada, and H Watanabe, and T Mitsuya, and F Sagawa
June 1994, Revista medica de Chile,
S Okada, and Y Miyoshi, and Y Takizawa, and S Hagiwara, and H Mori, and H Niikura, and H Terada, and H Watanabe, and T Mitsuya, and F Sagawa
July 2004, Internal medicine (Tokyo, Japan),
Copied contents to your clipboard!